PMA P150025S015

Device
PD-L1 IHC 28-8 pharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P150025
Supplement
S015
Product code
PLS
Decision date
2022-07-22
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Approval order statement
Update of manufacturing documents relating to Post-QC testing.

Current openFDA PMA Record#

Device
PD-L1 IHC 28-8 pharmDx
Applicant
Agilent Technologies, Inc.
PMA number
P150025
Supplement
S015
Product code
PLS
Generic name
Immunohistochemistry assay, antibody, programmed death-ligand 1
Decision date
2022-07-22
Decision code
OK30
Date received
2022-06-17
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Update of manufacturing documents relating to Post-QC testing.